![]() |
|
|
Vol. 295, Issue 2, 844-851, November 2000
Pharmacogenetics Research Institute (Y.S., L.-S.W., Z.-H.X., N.H.,
W.W., S.-L.H., H.-H.Z.) and Department of Pathophysiology (W.-M.X.),
Hunan Medical University, Changsha, China
It has been previously reported that omeprazole (OP) oxidation is
mediated by CYP2C19 and CYP3A4 in human livers. In this study, we
assessed their relative contributions with human liver microsomal
fractions from Chinese populations that were genotyped by
CYP2C19 and recruited from two ethnic groups, Han and
Zhuang. The kinetics of 5-hydroxyomeprazole (5-OH-OP) formation was
best described by the two-enzyme and single-enzyme Michaelis-Menten equations for liver microsomes from CYP2C19 extensive (EMs) and poor
metabolizers, respectively. At a low substrate concentration that may be encountered in vivo, the monoclonal antibody to CYP2C8/9/19 strongly inhibited 5-OH-OP formation in EM microsomes, whereas troleandomycin (TAO) eliminated most of the formation at a high substrate concentration. In poor metabolizer microsomes, either TAO or
anti-CYP3A4 could alone abolish 5-OH-OP formation. Furthermore, there
were differences between homozygous and heterozygous EMs in the
percentage of inhibition by TAO and the antibodies. At the low
substrate concentration, OP 5-hydroxyaltion was correlated well with
S-mephenytoin 4'-hydroxylation and CYP2C19 contents in
liver microsomes of 34 Chinese individuals. Moreover, in these individuals, obviously genetic and somewhat ethnic differences in OP
5-hydroxylation were observed between different CYP2C19 genotypes (wt/wt > wt/m1 > m1/m1) and between Han and Zhuang (Han > Zhuang),
respectively. The results indicate that CYP2C19 is a high-affinity
enzyme for OP 5-hydroxylation by liver microsomes from Chinese
individuals and that its contribution is CYP2C19 gene
dependent and ethnically related. Similar studies indicate that OP
sulfoxidation is mediated mainly by CYP3A4 and independent of
CYP2C19 genotype status.
This article has been cited by other articles:
![]() |
Z.-Q. Liu, B. Zhu, Y.-F. Tan, Z.-R. Tan, L.-S. Wang, S.-L. Huang, Y. Shu, and H.-H. Zhou O-Dealkylation of Fluoxetine in Relation to CYP2C19 Gene Dose and Involvement of CYP3A4 in Human Liver Microsomes J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||